Bohnsack Pharma Consulting

Commercialization Services for the German Generic Pharmaceutical Market

The Executive Advantage

Turnkey Market Entry Without the Corporate Overhead

Building an internal commercial department, regulatory team, and sales infrastructure in Germany is a massive, high-risk capital investment. Bohnsack Pharma Consulting replaces the costly necessity of setting up an entire pharmaceutical company.

By serving as your outsourced, end-to-end commercial operations partner, this consultancy delivers immediate, expert-level market access, distribution, and tender management at a fraction of the cost of building a local corporate infrastructure.

Core Service Offerings

1. Direct-to-Market Generic Concepts

Delivering strategic commercial models across multi-channel frameworks to secure rapid market penetration for generic pharmaceuticals:

• B2B (Business-to-Business): Commercial alignments with supply chain partners.
• B2C (Business-to-Consumer): Direct retail optimization models.
• B2G (Business-to-Government): Institutional procurement strategies for the public sector.

2. Retail Channel Management & Supply Chain Optimization

Directing end-to-end commercial operations across the entire German retail and distribution ecosystem:

• Payer Relations: Strategic coordination with individual sick funds and sick fund groups.
• Dispensing Networks: Comprehensive sales management for retail pharmacies.
• Logistics & Distribution: Commercial alignment with pre-wholesalers, centralized warehouses, and full-line wholesalers.

3. Strategic Product Lifecycle & Corporate Consulting

Organizing and executing critical business milestones to drive operational growth and structural agility:

• Pre-Launch Readiness: Commercial market assessment and tactical entry planning.
• Launch & Re-Launch Execution: Driving high-impact market entry strategies for new and established generics.
• Post-Launch Strategy: Continuous lifecycle management to defend volume and sustain profitability.
• Corporate Transformation: Expert advisory for setting up, restructuring, and organizational re-shaping of pharmaceutical companies.

4. Institutional Hospital Channel Management

Maximizing commercial footprint and securing high-volume procurement contracts within clinical networks:

• Procurement Access: Navigating institutional buying groups, hospitals, and hospital pharmacies.
• Stakeholder Alignment: Developing and maintaining Key Opinion Leader (KOL) networks.
• Commercial Execution: Structuring institutional contracting models and executing clinical marketing initiatives.
• Direct Sales Operations: Management and oversight of specialized field force direct sales channels.

5. Data Analytics & Commercial Intelligence

Transforming complex pharmaceutical data points into strategic, long-term commercial advantages:

• Market Insight Access: Delivering targeted tender data, hospital procurement metrics, and established KOL contacts.
• Predictive Modeling: Long-term forecasting for supply volumes, overall sales, and market share (MS) shifts.
• Margin Protection: Advanced tracking of price erosion dynamics alongside two-year forward-looking pricing structures